Court's FDA Ruling Puts the Squeeze on CME

"First Amendment--what is that? The FDA believes the Bill of Rights starts with number two," quipped David G. Adams, attorney with the Venable Firm in Washington, D.C. Formerly with the Food and Drug Administration, Adams has switched camps and is now in private practice representing biomedical companies.

On that note, Adams began his analysis of the recent court ruling curtailing the FDA's power to regulate pharmaceutical and medical device companies.

He addressed the first p

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish